Outcomes of Retinal Re-surgeries in Silicone Oil Filled Eyes
NCT ID: NCT06583798
Last Updated: 2024-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
33 participants
OBSERVATIONAL
2023-01-01
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Same Day Closure of Giant Macular Hole With Silicone Oil
NCT06915948
Retinal Redetachment After Silicone Oil Removal : a Risk Factor Analysis
NCT05647928
Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment
NCT03618498
Duration of Silicone Oil Tamponade on Foveal and Parafoveal Thickness in Rhegmatogenous Retinal Detachment
NCT05817630
Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye
NCT02201706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* structured questionnaire will be used to collect information regarding systemic diseases including Diabetes mellitus and its duration, Hypertension, Dyslipidemia , any cardiovascular diseases, any history of ocular trauma or any other ocular comorbidities.
* Details of the primary retinal surgery including indication, date of surgery, Name of the procedure will be noted
* Details of re surgery including indication (retinal pathology), timing of the re surgery from the primary surgery, preoperative Best Corrected Visual Acuity(BCVA) A using log MAR (Minimum Angle of resolution)) chart at 3 meters, intra ocular pressure using non contact Reichert 7 tonometry will be noted.
* Slit lamp bio-microscopy of the anterior segment using Topcon slit lamp biomicroscope,90 Diopter lens examination and indirect ophthalmoscopy with 20 Diopter lens of the fundus will be done.
* Spectral domain OCT(Optical coherence Tomography) with Zeiss Cirrus HD OCT (High Definition- Optical Coherence tomography) machine will be done for documentation of the status of macula in whichever cases possible.
* Re surgery will be done by a single Senior consultant in all the cases. Alcon Luxor Biomicroscope with Non contact BIOM (binocular indirect ophthalmomicroscope ) viewing system will be used. 2 ports will be made. Top up of Silicone oil will be done whenever needed. Membrane peeling with relaxing retinectomy / drainage retinotomy , haemostasis and endolaser will be done under Silicone oil as required. After the re surgery, the patient will be advised to maintain prone position.
* After the re surgery the BCVA(Best Corrected Visual Acuity), IOP (Intraocular pressure) will be noted on first visit at 15 days, 3rd month and 6th month follow up.
* Fundus examination will be done at all visits. Spectral Domain OCT(Optical coherence Tomography) will be done at all visits to see the status of macula.
STATISTICAL ANALYSIS
* Data entry will be done in Microsoft excel and analysed using the latest SPSS (Statistical Package for the Social Sciences) software.
* Wherever required, descriptive analysis will be done
* Chi square test will be used to find the statistical significance among the qualitative data, •two-tail t test will be used to find statistical significance among the quantitative data pre and post operatively.
* Other statistical tests will be used depending upon the need for post hoc analysis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resurgery In Silicone Oil Filled Eyes
* Alcon Luxor Biomicroscope with Non-contact BIOM (binocular indirect ophthalmomicroscope) viewing system was used.
* 2 ports were made in Pars plana.
* Top up of Silicone oil was done whenever needed.
* Membrane peeling with relaxing retinectomy / drainage retinotomy, haemostasis and endolaser were done under Silicone oil as required.
* After the re surgery, the patients were advised to maintain prone position.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients whose proper follow up to 6 months after re surgery were maintained during the study period.
* No history of any additional eye disease other than h/o cataract surgery or primary RD repair.
* Patients who were willing to be a part of the study and willing to provide informed written consent.
Exclusion Criteria
* Patients who had history of ocular trauma after the primary surgery.
* Patients who have any other ocular comorbidities other than cataract.
* Patients who had undergone multiple previous re surgeries for retinal detachment.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ahalia Foundation Eye Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Saurav Mahajan
Principal Investigator, Clinical Professor Adjunct
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rajkumar Maheshwari, MS
Role: PRINCIPAL_INVESTIGATOR
Ahalia Foundation Eye Hospital
C R Asla Jahan, DNB
Role: PRINCIPAL_INVESTIGATOR
Ahalia Foundation Eye Hospital
Saurav Mahajan, MS
Role: PRINCIPAL_INVESTIGATOR
Ahalia Foundation Eye Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahaliafoundation Eye Hospital
Palakkad, Kerala, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-1312-4448
Identifier Type: OTHER
Identifier Source: secondary_id
TP232602676
Identifier Type: OTHER
Identifier Source: secondary_id
202201.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.